tradingkey.logo

Vape maker Ispire misses fiscal 2025 revenue estimates, shifts focus to nicotine sector

ReutersSep 16, 2025 11:13 AM


Overview

  • Ispire Technology fiscal 2025 revenue falls to $127.5 mln, missing analyst expectations

  • Net loss widens to $39.2 mln from $14.8 mln in fiscal 2024

  • Company shifts focus from cannabis to nicotine sector, prioritizing quality customers


Outlook

  • Ispire sees $18 mln in backlog orders entering fiscal Q1 2026

  • Company focuses on nicotine sector for sustainable growth

  • Ispire progressing preparations for advancing PMTA submissions for flavored ENDS products

  • Company's international nicotine ODM business gaining momentum


Result Drivers

  • REVENUE DECLINE - Revenue fell to $127.5 mln from $151.9 mln in FY 2024, attributed to strategic shift from cannabis to nicotine sector

  • GROSS MARGIN DROP - Gross margin decreased to 17.8% from 19.6% in FY 2024, impacted by strategic repositioning away from cannabis

  • OPERATING EXPENSES - Operating expenses rose to $60.5 mln due to increased sales and marketing costs, despite cost-cutting measures, according to Co-CEO Michael Wang


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

FY Revenue

Miss

$127.50 mln

$148.90 mln (1 Analyst)

FY Net Income

-$39.20 mln

FY Gross Margin

17.8%

FY Gross Profit

$22.60 mln

FY Operating Expenses

$60.50 mln


Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the tobacco peer group is "buy"

  • Wall Street's median 12-month price target for Ispire Technology Inc is $7.50, about 54.3% above its September 15 closing price of $3.43

Press Release: ID:nPnrjvF1a

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Tradingkey
KeyAI